All Stories

  1. Detection of Phosphorylated Insulin Receptor in Colorectal Adenoma and Adenocarcinoma: Implications for Prognosis and Clinical Outcome
  2. Identification of Pivotal Cellular Factors Involved in HPV‐Induced Dysplastic and Neoplastic Cervical Pathologies
  3. The human papillomavirus-16 E7 oncoprotein exerts antiapoptotic effects via its physical interaction with the actin-binding protein gelsolin
  4. Sgk1 enhances RANBP1 transcript levels and decreases taxol sensitivity in RKO colon carcinoma cells
  5. Understanding the targeting of the RB family proteins by viral oncoproteins to defeat their oncogenic machinery
  6. Androgen receptor serine 81 mediates Pin1 interaction and activity
  7. New insights in endometrial carcinogenesis
  8. Determination of SGK1 mRNA in non-small cell lung cancer samples underlines high expression in squamous cell carcinomas
  9. Wasting lives: The effects of toxic waste exposure on health. The case of Campania, Southern Italy
  10. Reducing the risk of overdiagnosis in lung cancer: A support from molecular biology
  11. Retinoblastoma-independent antiproliferative activity of novel intracellular antibodies against the E7 oncoprotein in HPV 16-positive cells
  12. Gender-related disparities in non-small cell lung cancer
  13. Cathepsin B inhibition interferes with metastatic potential of human melanoma: an in vitro and in vivo study
  14. Human Papillomavirus-16 E7 Interacts with Glutathione S-Transferase P1 and Enhances Its Role in Cell Survival
  15. Intracellular presence of insulin and its phosphorylated receptor in non‐small cell lung cancer
  16. Sgk1 activates MDM2-dependent p53 degradation and affects cell proliferation, survival, and differentiation
  17. Correlation between melanogenic and catalase activity in in vitro human melanocytes: a synergic strategy against oxidative stress
  18. Interaction Between the Cdk2/Cyclin A Complex and a Small Molecule Derived from the pRb2/p130 Spacer Domain: A Theoretical Model
  19. Protease‐mediated arsenic prodrug strategy in cancer and infectious diseases: A hypothesis for targeted activation
  20. Human papillomavirus‐16 E7 interacts with siva‐1 and modulates apoptosis in HaCaT human immortalized keratinocytes
  21. Unravelling the Complexity of T Cell Abnormalities in Common Variable Immunodeficiency
  22. New Technologies Used in the Study of Human Melanoma
  23. A small molecule based on the pRb2/p130 spacer domain leads to inhibition of cdk2 activity, cell cycle arrest and tumor growth reduction in vivo
  24. Retinoblastoma family proteins as key targets of the small DNA virus oncoproteins
  25. Multiple interference of the human papillomavirus-16 E7 oncoprotein with the functional role of the metastasis suppressor Nm23-H1 protein
  26. Pkn Is a novel partner of cyclin T2a in muscle differentiation
  27. Ferritin light chain down‐modulation generates depigmentation in human metastatic melanoma cells by influencing tyrosinase maturation
  28. In vitro and in vivo tumor growth inhibition by a p16‐mimicking peptide in p16INK4A‐defective, pRb‐positive human melanoma cells
  29. Characterization of tissue specific expression of Notch‐1 in human tissues
  30. Analysis of APAF‐1 expression in human cutaneous melanoma progression
  31. RACK1 is a functional target of the E1A oncoprotein
  32. Distribution of the Serine Protease HtrA1 in Normal Human Tissues
  33. SP-22 Analysis of APAF-1 Expression in Human Cutaneous Melanoma Progression
  34. Genetic and epigenetic alterations as hallmarks of the intricate road to cancer
  35. Emerging roles of DNA tumor viruses in cell proliferation: new insights into genomic instability
  36. cDNA array technology in melanoma: An overview
  37. Identification of genes down‐regulated during melanoma progression: a cDNA array study
  38. Cyclin T: Three forms for different roles in physiological and pathological functions
  39. The HtrA1 serine protease is down-regulated during human melanoma progression and represses growth of metastatic melanoma cells
  40. Pattern of Expression of Cyclin T1 in Human Tissues
  41. Cyclin T2A Gene Maps on Human Chromosome 2q21
  42. Association for Molecular Pathology: Sixth annual meeting in Denver, November 9–12, 2000
  43. The retinoblastoma-related Rb2/p130 gene is an effector downstream of AP-2 during neural differentiation
  44. Interplay between the antimetastatic nm23 and the Retinoblastoma-related Rb2/p130 genes in promoting neuronal differentiation of PC12 cells
  45. Retinoblastoma family proteins induce differentiation and regulate B-myb expression in neuroblastoma cells
  46. Expression of AP‐2 transcription factor and of its downstream target genes c‐kit, E‐cadherin and p21 in human cutaneous melanoma
  47. A serine 37 mutation associated with two missense mutations at highly conserved regions of p53 affect pro-apoptotic genes expression in a T-lymphoblastoid drug resistant cell line
  48. nm23: Unraveling its biological function in cell differentiation
  49. nm23: Unraveling its biological function in cell differentiation
  50. Interaction between the pRb2/p130 C-terminal domain and the N-terminal portion of cyclin D3
  51. Enhancement of doxorubicin content by the antitumor drug lonidamine in resistant ehrlich ascites tumor cells through modulation of energy metabolism
  52. The RB-related gene Rb2/p130 in neuroblastoma differentiation and in B-myb promoter down-regulation
  53. Retinoblastoma-related protein pRb2/p130 and its binding to theB-myb promoter increase during human neuroblastoma differentiation
  54. Retinoblastoma‐related protein pRb2/p130 and its binding to the Bmyb promoter increase during human neuroblastoma differentiation
  55. Activation of human B-MYB by cyclins
  56. Retinoblastoma protein family in cell cycle and cancer: A review
  57. Retinoblastoma protein family in cell cycle and cancer: A review
  58. The Rb2/p130 gene product is a nuclear protein whose phosphorylation is cycle regulated
  59. Rhein inhibits glucose uptake in Ehrlich ascites tumor cells by alteration of membrane-associated functions
  60. Inhibition of membrane redox activity by rhein and adriamycin in human glioma cells
  61. Glucose utilization by tumor cells: A post-translational modification of mitochondrial hexokinase may play a regulatory role
  62. The Potential Role of Lonidamine in the Combined Treatment of Malignant Gliomas. A Randomized Study
  63. Inhibition of protein synthesis in neoplastic cells by rhein
  64. The potential role of lonidamine (LND) in the treatment of malignant glioma
  65. pp-120: A common endogenous substrate for insulin and IGF-1 receptor-associated tyrosine kinase activity in the highly malignant AS-30D rat hepatoma cells
  66. The Role of Mitochondrial Hexokinase in Neoplastic Phenotype and Its Sensitivity to Lonidamine a
  67. Modulation of adriamycin uptake by lonidamine in ehrlich ascites tumor cells
  68. Effect of lonidamine on human malignant gliomas: Biochemical studies
  69. Integration of Mitochondrial Function with High Aerobic Glycolysis in Tumors: Role of Hexokinase Binding to the Outer Mitochondrial Membrane
  70. Effect of lonidamine on the utilization of 14C-labeled glucose by human astrocytoma cells
  71. Effect of hyperthermia on electron transport in ehrlich ascites tumor mitochondria
  72. Effect of adriamycin on electron transport in rat heart, liver, and tumor mitochondria
  73. The effect of gossypol and lonidamine on electron transport in ehrlich ascites tumor mitochondria
  74. Effects of Lonidamine on Murine and Human Tumor Cells in vitro
  75. Changes of Energy Metabolism in the Germ Cells and Ehrlich Ascites Tumor Cells
  76. Growth Control by the Retinoblastoma Gene Family
  77. Synthetic Oligopeptides as Cancer Cell Cycle Modulators